In addition, it can also inhibit the progression of SMAD4-deficient pancreatic cancer by enhancing AMPK-mediated phosphorylation and ubiquitination degradation of HNF4G protein, providing the possibility of targeted therapy for pancreatic cancer69. This evidence concerns the gene SMAD4 and pancreatic neoplasm.